Abstract
Many cases of myeloid malignancies are associated with recurring cytogenetic aberrations. Chromosomal analysis can aid in diagnosis, predict prognosis, and disclose subsequent clonal evolution. Three different cell culture methods: direct harvest, nonsynchronized culture, and synchronized culture are usually prepared if the nucleated cell counts in marrow blood are sufficient. Synchronized culture is the first choice of method in myeloid malignancies, whereas the direct method can be omitted if the cell count is low. The aseptic culture technique is strictly followed until harvesting procedure. For synchronized culture, uridine and fluorodeoxyuridine are added as blocking reagents and released by thymidine on the following day. Harvesting steps of the cultures involved colcemid exposure, hypotonic treatment, and Carnoy’s fixation. The cells are then ready for slide making and banding for chromosomal analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) World Health Organization classification of tumours. Pathology and genetics of tumours of hematopoietic and lymphoid tissues. IARC, Lyon
Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100(7):2292–2302
Bennett JM, Catovsky D, Daniel MT et al (1976) Proposals for the classification of the acute leukaemia: French-American-British. Cooperative Group. Br J Haematol 33:451–458
Swerdlow SH, Campo E, Harris NL et al (eds) (2008) WHO classification of tumours of hematopoietic and lymphoid tissues. IARC, Lyon
Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405
Grimwade D, Hills RK, Moorman AV et al (2010) Refinement of cytogenetic classification in acute myeloid leukaemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116(3):354–365
Dunn B, Mouchrani P, Keagle M (eds) (2005) The cytogenetic symposia, 2nd edn. Association of Genetic Technologists, Olathe, KS
Dunn B, McMorrow LE (2008) Cytogenetic study guide. Foundation for Genetic Technology, Lenexa, KS
Hopwood VL, Gu J, Zhao M (eds) (2011) The cytogenetic technology program: A comprehensive review in clinical cytogenetics. MD Anderson Cancer Center, Houston, TX
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Hui, E.K.C., Wan, T.S.K., Ng, M.H.L. (2017). Chromosome Preparation for Myeloid Malignancies. In: Wan, T. (eds) Cancer Cytogenetics. Methods in Molecular Biology, vol 1541. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6703-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6703-2_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6701-8
Online ISBN: 978-1-4939-6703-2
eBook Packages: Springer Protocols